Table 2. Competitive ELISA assay of monoclonal antibodies against N protein.
MAbsa | HRP conjugated MAb (%)b | |||
H2A12 | H2H9 | H3E11 | M1D8 | |
H2A12 | 93 | 22 | 25 | 12 |
H2A4 | 75 | 16 | 17 | 21 |
H2E4 | 80 | 22 | 27 | 31 |
H2F4 | 77 | 19 | 22 | 25 |
H1C2 | 78 | 24 | 23 | 14 |
H4B9 | 80 | 22 | 31 | 11 |
H4C8 | 82 | 27 | 17 | 12 |
H4E11 | 80 | 31 | 13 | 11 |
H2H9 | 32 | 88 | 19 | 12 |
M7E11 | 88 | 30 | 15 | 32 |
M3E11 | 20 | 15 | 85 | 19 |
M1D8 | 20 | 23 | 14 | 90 |
Competing MAbs, SFTS patients derived were designated as “H” for the first letter; and mouse derived were designated as “M” for the first letter.
Percentage of binding inhibition of HRP conjugated detective antibodies in competitive ELISA assay.